NS-6740 hydrochloride
NS-6740 hydrochloride is a silent agonist of α7 nicotinic acetylcholine receptor (α7 nAChR) with an IC50 of 3 nM. NS-6740 hydrochloride reduces LPS-induced TNF-α release and regulates the cholinergic anti-inflammatory pathway. NS-6740 hydrochloride exerts anti-inflammatory effects. NS-6740 hydrochloride reduces long-term potentiation in hippocampal brain slices. NS-6740 hydrochloride can be used in research related to neuroinflammation and schizophrenia.
For research use only. We do not sell to patients.
- CAS No.: 753499-14-8
- Formula: C19H20ClF3N2O2
- Molecular Weight:400.82
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
NS-6740 (0.01-100 μM; 30 min) hydrochloride potently inhibits LPS-induced TNF-α release in enriched primary rat microglial cultures, achieving complete inhibition at concentrations of 50 and 100 μM. Co-treatment with a partial α7 nAChR agonist enhances this effect, which is not mediated by regulation of the MAPK pathway[1].
NS-6740 (5 μM; 60 s) hydrochloride induces persistent desensitization of α7 nAChR expressed in Xenopus laevis oocytes, and the desensitized receptors can be activated by the positive allosteric modulator PNU-120596 (HY-12152)[2].
NS-6740 hydrochloride acts as an antagonist of the recombinant 5-HT3A receptor expressed in HEK293 cells, with an IC50 value of 4827 nM[3].
NS-6740 hydrochloride binds to native rat α7 nAChR with high affinity, with a Ki value of 2.85 nM[3].
NS-6740 hydrochloride inhibits the activation of recombinant rat α7 nAChRs expressed in HEK293 cells induced by BMS-933043 (HY-W062702), with an IC50 value of 283 nM for peak current and 255 nM for net charge[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
NS-6740 (3-10 mg/kg; s.c.; single dose) hydrochloride, at doses achieving 89% and 98% α7 nAChR occupancy, does not enhance memory retention in the mouse novel object recognition task[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57Bl/6 (male, 25-30g)[3]
-
Dosage:10 mg/kg
-
Administration:s.c.; single dose
-
Result:Abolished the improved discrimination index seen in mice treated with BMS-933043 alone.
Achieved 98% α7 nAChR occupancy in mouse forebrain, with an average brain/plasma ratio >8.
-
Animal Model:C57Bl/6 (male, 25-30g)[3]
-
Dosage:3-10 mg/kg
-
Administration:s.c.; single dose
-
Result:Did not improve 24-hour novel object recognition memory in mice at 3 mg/kg and 10 mg/kg.
Achieved 89% α7 nAChR occupancy in mouse forebrain at 3 mg/kg, with an average brain/plasma ratio >8.
Chemical Information
-
CAS No. 753499-14-8
-
Molecular Weight 400.82
-
Formula C19H20ClF3N2O2
-
SMILES
O=C(N1CCN2CCC1CC2)C3=CC=C(C4=CC(C(F)(F)F)=CC=C4)O3.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Organotypic Brain Slice Culture
Organotypic brain slice culture is an ex vivo method in which CNS tissue slices are maintained on a stable support with culture medium and oxygen access, preserving tissue architecture, multiple resident brain cell types, and network organization better than dissociated cultures. The commonly used membrane-interface method places brain or hippocampal slices on a porous membrane insert at the air-liquid interface; culture medium reaches the tissue through the membrane while the slice remains oxygenated from the humidified incubator atmosphere. Readouts depend on the experimental aim: slice survival can be monitored by propidium iodide uptake or LDH release, tissue organization by immunostaining, live structural changes by repeated imaging, and neuronal/network function by electrophysiology or multi-electrode recordings.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
Purity & Documentation
References
[1]. Thomsen MS, et al. The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia. Journal of neuroimmunology. 2012 Oct 15;251(1-2):65-72. [Content Brief]
[2]. Papke RL, et al. NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity. Neuroscience letters. 2018 Jun 11;677:6-13. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)